[Endotoxic shock].
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D003428:Cross Infection / Q000150:complications; D003911:Dextrans / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004754:Enterobacter; D004926:Escherichia coli; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007545:Isoproterenol / Q000627:therapeutic use; D008353:Mannitol / Q000627:therapeutic use; D013511:Minor Surgical Procedures / Q000009:adverse effects; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011511:Proteus; D011550:Pseudomonas aeruginosa; D012772:Shock, Septic / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D014325:Tromethamine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D003911:Dextrans; D014325:Tromethamine; D010643:Phenoxybenzamine; D008353:Mannitol; D007545:Isoproterenol; D006854:Hydrocortisone
Choc endotoxinique.